|
KLF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.029600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.337600E-03 |
| Normal-vs-Stage2 |
2.253200E-01 |
| Normal-vs-Stage3 |
3.002900E-03 |
| Normal-vs-Stage4 |
4.284200E-02 |
| Stage1-vs-Stage2 |
4.081600E-01 |
| Stage1-vs-Stage3 |
3.499200E-01 |
| Stage1-vs-Stage4 |
6.517200E-01 |
| Stage2-vs-Stage3 |
1.290640E-01 |
| Stage2-vs-Stage4 |
3.091400E-01 |
| Stage3-vs-Stage4 |
8.685200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.402100E-02 |
| Normal-vs-AfricanAmerican |
1.289850E-02 |
| Normal-vs-Asian |
1.919720E-03 |
| Caucasian-vs-AfricanAmerican |
8.545400E-01 |
| Caucasian-vs-Asian |
9.161600E-02 |
| AfricanAmerican-vs-Asian |
1.394180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.269560E-02 |
| Normal-vs-Female |
2.115200E-01 |
| Male-vs-Female |
2.910200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.988500E-04 |
| Normal-vs-Extreme_Weight |
6.278200E-03 |
| Normal-vs-Obese |
2.601900E-02 |
| Normal-vs-Extreme_Obese |
2.506300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.886800E-01 |
| Normal_Weight-vs-Obese |
1.369640E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.968000E-01 |
| Extreme_Weight-vs-Obese |
3.529000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.883400E-01 |
| Obese-vs-Extreme_Obese |
3.176600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.162000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.113600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.961100E-03 |
| Normal-vs-Age(81-100Yrs) |
5.583200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.840400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.743600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.577980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.802000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.306400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.750600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.008400E-02 |
| Normal-VS-Type2 PRCC |
2.5108000000218E-06 |
| Normal-VS-KIRP CIMP |
2.764400E-01 |
| Normal-VS-Unclassified PRCC |
2.341200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.22640000000696E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.933800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.562000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.109900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.104100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.360200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.015080E-04 |
| Normal-vs-N1 |
1.258220E-02 |
| Normal-vs-N2 |
2.830400E-01 |
| N0-vs-N1 |
2.279600E-01 |
| N0-vs-N2 |
4.343600E-01 |
| N1-vs-N2 |
8.754000E-01 |
|
|
